Follow-up of Clinical Symptoms and Blood Concentration in Donepezil Overdose

Prim Care Companion CNS Disord. 2023 Sep 28;25(5):23cr03511. doi: 10.4088/PCC.23cr03511.

Authors

Koki Mori^{1

2}, Tatsuya Hirose¹, Tomohiro Matsumura³, Tomoaki Yoshimura¹

Affiliations

¹ Gifu Pharmaceutical University, Gifu, Japan.
² Corresponding Author: Koki Mori, BPharm, Department of Pharmacy, Ogaki Municipal Hospital, 4-86 Minaminokawa-cho, Ogaki-shi, Gifu 503-8502, Japan (forest_kouki@yahoo.co.jp).
³ Meijo University, Aichi, Nagoya, Japan.

PMID: 37788804
DOI: 10.4088/PCC.23cr03511

No abstract available

MeSH terms

Cholinesterase Inhibitors
Donepezil
Drug Overdose*
Follow-Up Studies
Humans
Piperidines*

Substances

Donepezil
Piperidines
Cholinesterase Inhibitors